OV
Roles
Therapeutic Areas
Orion Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Odronextamab (with Regeneron) | Relapsed/Refractory B-cell non-Hodgkin lymphomas | Phase 3 / Regulatory Review |
| Orion pain portfolio candidates | Chronic pain | Not Specified / Various |
| Neurological disease programs | e.g., Parkinson's disease | Not Specified |